Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors

Cancer
Christer LindholmSwedish Melanoma Study Group

Abstract

The objective of the current study was to compile prospective, population-based data on cutaneous invasive melanomas in Sweden during the period from 1990 to 1999, to describe and analyze survival data and prognostic factors, and to make comparisons with previously published Swedish and international data. Twelve thousand five hundred thirty-three patients, which included 97% of all registered melanomas in Sweden, were included and described. Among these, 9515 patients with clinical Stage I and II melanoma were included in an analysis of survival and in a univariate analysis, and 6191 patients were included in a multivariate analysis of prognostic factors. There was no significant change in melanoma incidence during 1990-1999. Favorable prognostic factors were found, especially in younger and female patients, resulting in a relative 5-year survival rate of 91.5%. In the multivariate analysis, significant factors that had a negative effect on survival were Clark level of invasion, Breslow thickness, ulceration, older patient age, trunk location, greatest tumor dimension, nodular histogenetic type, and male gender. During the period from 1990 to 1999, the 5-year survival of patients with malignant melanoma in Sweden was better co...Continue Reading

References

Dec 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L HafströmL Ostrup
Jan 2, 1991·International Journal of Cancer. Journal International Du Cancer·K Magnus
Apr 1, 1991·Archives of Surgery·U Veronesi, N Cascinelli
Apr 19, 1989·Journal of the National Cancer Institute·M ThörnU B Krusemo
Aug 1, 1980·International Journal of Cancer. Journal International Du Cancer·M PradeA Cochran
Dec 1, 1993·Cancer·N H CoxR M MacKie
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U JungneliusR Westberg
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J A SmithJ C Redburn
Mar 17, 1999·International Journal of Cancer. Journal International Du Cancer·C La VecchiaF Levi
Mar 22, 2000·Journal of the American Academy of Dermatology·D Czarnecki, C J Meehan
Aug 5, 2000·Cancer·G Cohn-CedermarkU Ringborg
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·L D MarrettB K Armstrong
May 3, 2001·Journal of the National Cancer Institute·A JemalM A Tucker
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchA Morabito
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchJ F Thompson
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M SantUNKNOWN EUROCARE Working Group
Dec 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BrayD M Parkin
Apr 30, 2002·International Journal of Cancer. Journal International Du Cancer·Kari HemminkiKamila Czene

❮ Previous
Next ❯

Citations

Apr 18, 2006·Current Treatment Options in Oncology·Marie-France Demierre
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R M MacKieA M M Eggermont
Nov 3, 2005·Journal of the National Cancer Institute·J Lorenzo Bermejo, Kari Hemminki
Feb 5, 2009·Pigment Cell & Melanoma Research·Thomas J HornyakFaith M Strickland
Jun 26, 2013·Anais Brasileiros De Dermatologia·Flavia Vieira BrandãoFlávia Vasques Bittencourt
Feb 6, 2008·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Sherrif F Ibrahim, Marc D Brown
Aug 29, 2012·Surgery·Michael E EggerKelly M McMasters
Dec 20, 2008·Clinics in Dermatology·Alexander J Stratigos, Andreas D Katsambas
Dec 20, 2008·Clinics in Dermatology·Michael J PayetteJane M Grant-Kels
Sep 18, 2007·Journal of the American Academy of Dermatology·Alan C GellerAmy L Yaroch
Jun 16, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·J PaoliA M Wennberg
Jan 16, 2007·The Australasian Journal of Dermatology·Scott BarkerMarius Rademaker
Dec 7, 2005·International Journal of Cancer. Journal International Du Cancer·Daniela Mihic-ProbstReinhard Dummer
Mar 21, 2007·International Journal of Cancer. Journal International Du Cancer·Pia M Karlsson, Mats Fredrikson
Sep 11, 2012·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·Ida BodénPeter Naredi
May 26, 2009·Hematology/oncology Clinics of North America·Alan C Geller
Sep 13, 2006·International Journal of Radiation Oncology, Biology, Physics·John FrenchJerry Cannon
Apr 6, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J LythC Ingvar
Jan 28, 2016·International Journal of Cancer. Journal International Du Cancer·Hanna ErikssonTherese M-L Andersson
May 2, 2015·Journal of the American Academy of Dermatology·Britta KrynitzBernt Lindelöf
Nov 2, 2011·Journal of the American Academy of Dermatology·Alan C GellerAllan C Halpern
Apr 16, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H ErikssonJ Hansson
Feb 24, 2015·Journal of the American Academy of Dermatology·UNKNOWN American Academy of Dermatology Ad Hoc Task Force for the ABCDEs of MelanomaWendy Smith Begolka
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Johan HanssonInger Rosdahl
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Phyllis A GimottyDuPont Guerry
Apr 17, 2018·International Journal of Cancer. Journal International Du Cancer·Melina ArnoldIsabelle Soerjomataram
Aug 12, 2017·International Journal of Cancer. Journal International Du Cancer·Deborah UtjésHanna Eriksson
May 1, 2019·Nature Biomedical Engineering·Dale J WaterhouseSarah E Bohndiek
Sep 6, 2019·The British Journal of Dermatology·H Tufvesson StillerM Schmitt-Egenolf
Apr 12, 2018·Anais Brasileiros De Dermatologia·Ana Carolina Figueiredo Pereira CherobinFlávia Vasques Bittencourt
Apr 9, 2010·Melanoma Research·Konstantinos G LasithiotakisClaus Garbe
Jan 27, 2021·International Journal of Cancer. Journal International Du Cancer·Lidia SacchettoRoberto Zanetti
Jan 8, 2021·JNCI Cancer Spectrum·Mary-Ann El SharouniCarla Henrica van Gils
Jan 1, 2018·Anais Brasileiros De Dermatologia·Ana Carolina Figueiredo Pereira CherobinFlávia Vasques Bittencourt
Feb 26, 2021·Journal of Cancer Research and Clinical Oncology·L SusokT Gambichler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.